Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
4%
upside
4 price targets
|
0
%
|
|
|
|
3%
upside
6 price targets
|
0
%
|
|
|
|
3%
upside
11 price targets
|
0
%
|
|
|
554
Norfolk Southern
NSC
$67.2B
|
3%
upside
9 price targets
|
0
%
|
|
|
3%
upside
10 price targets
|
0
%
|
|
|
|
3%
upside
3 price targets
|
0
%
|
|
|
|
3%
upside
11 price targets
|
0
%
|
|
|
|
3%
upside
8 price targets
|
0
%
|
|
|
|
3%
upside
12 price targets
|
0
%
|
|
|
|
3%
upside
7 price targets
|
0
%
|
|
|
561
United Therapeutics
UTHR
$21.5B
|
3%
upside
5 price targets
|
0
%
|
|
|
3%
upside
11 price targets
|
0
%
|
|
|
|
3%
upside
11 price targets
|
0
%
|
|
|
|
3%
upside
8 price targets
|
0
%
|
|
|
|
3%
upside
10 price targets
|
0
%
|
|
|
|
3%
upside
7 price targets
|
0
%
|
|
|
|
2%
upside
8 price targets
|
0
%
|
|
|
|
2%
upside
18 price targets
|
0
%
|
|
|
|
2%
upside
6 price targets
|
0
%
|
|
|
|
2%
upside
9 price targets
|
0
%
|
|
|
|
2%
upside
7 price targets
|
0
%
|
|
|
|
2%
upside
3 price targets
|
0
%
|
|
|
|
2%
upside
10 price targets
|
0
%
|
|
|
|
2%
upside
7 price targets
|
0
%
|
|
|
|
2%
upside
4 price targets
|
0
%
|
|